ImmunoGeneTeqs (IGT) was established in June 2019 with the aim of providing methods to control inflammation and immune-related diseases based on more advanced genetic analysis technology. IGT's core technology, TAS-seq, provides better results in various genetic analyses. Based on the TAS-seq method, IGT provides comprehensive genetic analysis services including single-cell gene expression and immune receptor repertoire analysis.
All
Products
Resources
News
FAQ
Search